Accumulating evidence shows that gradual loss of white matter integrity plays an important role in the development of Alzheimer disease (AD).
Objective
The aim of this research was to study the microstructural integrity of white matter in AD in vivo.
Methods
Global fractional anisotropy, global axial diffusivity (AxD), and global radial diffusivity (RD) were analyzed in subjects with normal controls (NC), mild cognitive impairment (MCI), and AD using Alzheimer's Disease Neuroimaging Initiative data (total N = 210). We further compared specific white matter tracts among the 3 groups.
Results
Compared with the NC group, the MCI group had significantly increased global AxD and global RD. Compared with the NC and MCI groups, the AD group had significantly decreased global fractional anisotropy, increased global AxD, and increased global RD. With regard to specific white matter tracts, in the MCI group, we found increased AxD and increased RD in the external capsule, part of the lateral cholinergic pathway, in addition to the tracts connecting the limbic regions, predominantly in the left hemisphere. In the AD group, white matter abnormalities were widespread, including in the external capsule (cholinergic pathway) and limbic region tracts as well as tracts connecting anterior to posterior regions bilaterally.
Conclusions
The radiographic manifestation of damaged white matter microstructural integrity in the cholinergic pathway in MCI patients may provide a rational basis for the use of cholinesterase inhibitor drugs in the MCI stage of AD.
KantarciK.Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease. Expert Rev Neurother. 2005; 5: 663–670.
2.
StoutJC, JerniganTL, ArchibaldSL, . Association of dementia severity with cortical gray matter and abnormal white matter volumes in dementia of the Alzheimer type. Arch Neurol. 1996; 53: 742–749.
3.
KilimannI, GrotheM, HeinsenH, . Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study. J Alzheimers Dis. 2014; 40: 687–700.
4.
TeipelSJ, MeindlT, GrinbergL, . The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study. Hum Brain Mapp. 2011; 32: 1349–1362.
5.
SchliebsR, ArendtT.The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm. 2006; 113: 1625–1644.
6.
TeipelSJ, GrotheM, ListaS, . Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease. Med Clin North Am. 2013; 97: 399–424.
7.
MasdeuJC, KreislWC, BermanKF.The neurobiology of Alzheimer disease defined by neuroimaging. Curr Opin Neurol. 2012; 25: 410–420.
8.
Chevalier-LarsenE, HolzbaurEL.Axonal transport and neurodegenerative disease. Biochim Biophys Acta. 2006; 1762: 1094–1108.
9.
GoldBT, JohnsonNF, PowellDK, . White matter integrity and vulnerability to Alzheimer's disease: preliminary findings and future directions. Biochim Biophys Acta. 1822; 2012: 416–422.
10.
StokinGB, LilloC, FalzoneTL, . Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science. 2005; 307: 1282–1288.
11.
AgostaF, PievaniM, SalaS, . White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology. 2011; 258: 853–863.
12.
CanuE, McLarenDG, FitzgeraldME, . Microstructural diffusion changes are independent of macrostructural volume loss in moderate to severe Alzheimer's disease. J Alzheimers Dis. 2010; 19: 963–976.
13.
SalatDH, TuchDS, van der KouweAJ, . White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol Aging. 2010; 31: 244–256.
14.
StrickerNH, SalatDH, FoleyJM, . Decreased white matter integrity in neuropsychologically defined mild cognitive impairment is independent of cortical thinning. J Int Neuropsychol Soc. 2013; 19: 925–937.
15.
OishiK, MielkeMM, AlbertM, . DTI analyses and clinical applications in Alzheimer's disease. J Alzheimers Dis. 2011; 26(suppl 3): 287–296.
16.
BoschB, Arenaza-UrquijoEM, RamiL, . Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance. Neurobiol Aging. 2012; 33: 61–74.
ClerxL, VisserPJ, VerheyF, . New MRI markers for Alzheimer's disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements. J Alzheimers Dis. 2012; 29: 405–429.
19.
SextonCE, KaluUG, FilippiniN, . A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 2011; 32: 2322.e5–e18.
20.
DouaudG, JbabdiS, BehrensTE, . DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. Neuroimage. 2011; 55: 880–890.
21.
WeinerMW, VeitchDP, AisenPS, . The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 2012; 8: S1–S68.
22.
NirTM, JahanshadN, Villalon-ReinaJE, . Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging. Neuroimage Clin. 2013; 3: 180–195.
23.
MoriS, OishiK, JiangH, . Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage. 2008; 40: 570–582.
BrunA, EnglundE.A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol. 1986; 19: 253–262.
26.
EnglundE, BrunA, AllingC.White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. Brain. 1988; 111(Pt 6): 1425–1439.
27.
SjobeckM, HaglundM, EnglundE.Decreasing myelin density reflected increasing white matter pathology in Alzheimer's disease—a neuropathological study. Int J Geriatr Psychiatry. 2005; 20: 919–926.
28.
KowallNW, KosikKS.Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease. Ann Neurol. 1987; 22: 639–643.
29.
StahlR, DietrichO, TeipelSJ, . White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques. Radiology. 2007; 243: 483–492.
30.
SydykovaD, StahlR, DietrichO, . Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease: a diffusion tensor imaging and voxel-based morphometry study. Cereb Cortex. 2007; 17: 2276–2282.
31.
TeipelSJ, StahlR, DietrichO, . Multivariate network analysis of fiber tract integrity in Alzheimer's disease. Neuroimage. 2007; 34: 985–995.
32.
ZimnyA, SzewczykP, TrypkaE, . Multimodal imaging in diagnosis of Alzheimer's disease and amnestic mild cognitive impairment: value of magnetic resonance spectroscopy, perfusion, and diffusion tensor imaging of the posterior cingulate region. J Alzheimers Dis. 2011; 27: 591–601.
33.
FjellAM, AmlienIK, WestlyeLT, . Mini-mental state examination is sensitive to brain atrophy in Alzheimer's disease. Dement Geriatr Cogn Disord. 2009; 28: 252–258.
34.
HeoJH, LeeST, KonC, . White matter hyperintensities and cognitive dysfunction in Alzheimer disease. J Geriatr Psychiatry Neurol. 2009; 22: 207–212.
35.
BehlP, BoctiC, SwartzRH, . Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients. Arch Neurol. 2007; 64: 266–272.
36.
BoctiC, SwartzRH, GaoFQ, . A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia. Stroke. 2005; 36: 2126–2131.
37.
KimHJ, MoonWJ, HanSH.Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia. J Alzheimers Dis. 2013; 35: 129–136.
38.
MedinaD, DeToledo-MorrellL, UrrestaF, . White matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study. Neurobiol Aging. 2006; 27: 663–672.
39.
SeldenNR, GitelmanDR, Salamon-MurayamaN, . Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain. 1998; 121(Pt 12): 2249–2257.
40.
LikitjaroenY, MeindlT, FrieseU, . Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study. Eur Arch Psychiatry Clin Neurosci. 2012; 262: 341–350.
41.
KilimannI, LikitjaroenY, HampelH, . Diffusion tensor imaging to determine effects of antidementive treatment on cerebral structural connectivity in Alzheimer's disease. Curr Pharm Des. 2013; 19: 6416–6425.
42.
ShahA, JhawarSS, GoelA.Analysis of the anatomy of the Papez circuit and adjoining limbic system by fiber dissection techniques. J Clin Neurosci. 2012; 19: 289–298.
43.
TriarhouLC.Centenary of Christfried Jakob's discovery of the visceral brain: an unheeded precedence in affective neuroscience. Neurosci Biobehav Rev. 2008; 32: 984–1000.
44.
HornbergerM, WongS, TanR, . In vivo and post-mortem memory circuit integrity in frontotemporal dementia and Alzheimer's disease. Brain. 2012; 135: 3015–3025.
DelbeuckX, Van der LindenM, ColletteF. Alzheimer's disease as a disconnection syndrome?Neuropsychol Rev. 2003; 13: 79–92.
47.
ThompsonPM, HayashiKM, de ZubicarayG, . Dynamics of gray matter loss in Alzheimer's disease. J Neurosci. 2003; 23: 994–1005.
48.
AlvesGS, O'DwyerL, JurcoaneA, . Different patterns of white matter degeneration using multiple diffusion indices and volumetric data in mild cognitive impairment and Alzheimer patients. PLoS One. 2012; 7: e52859.
49.
ZhangY, SchuffN, JahngGH, . Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology. 2007; 68: 13–19.
